MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+38.64%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$87.2M
AUM Growth
+$87.2M
(+15%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-49.58%
Top 10 Holdings %
Top 10 Hldgs %
99.97%
Holding
12
New
–
Increased
1
Reduced
4
Closed
1
Top Buys
| 1 |
TG Therapeutics
TGTX
|
$619K |
Top Sells
| 1 |
Curis
CRIS
|
$36.8M |
| 2 |
Stoke Therapeutics
STOK
|
$3.68M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
$2.19M |
| 4 |
BridgeBio Pharma
BBIO
|
$1.19M |
| 5 |
Wave Life Sciences
WVE
|
$31.6K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $40.5M | 46.45% | 7,044,500 -5,500 | -0.1% | -$31.6K |
|
2
Invivyd
IVVD
$204M
| $15.7M | 18.03% | 9,248,250 | – | – |
|
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $10.7M | 12.3% | 523,280 -107,100 | -17% | -$2.19M |
|
|
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
| $4.57M | 5.24% | 197,700 | – | – |
|
|
SLN
5
Silence Therapeutics
SLN
$227M
| $3.57M | 4.1% | 363,800 | – | – |
|
|
6
BridgeBio Pharma
BBIO
$9.89B
| $3.2M | 3.67% | 121,200 -45,000 | -27% | -$1.19M |
|
|
7
Curis
CRIS
$20.9M
| $2.78M | 3.19% | 421,951 -5,578,049 | -93% | -$36.8M |
|
8
ProQR Therapeutics
PRQR
$237M
| $2.48M | 2.85% | 1,910,600 | – | – |
|
9
Arrowhead Research
ARWR
$3.05B
| $1.81M | 2.08% | 67,400 | – | – |
|
|
10
TG Therapeutics
TGTX
$4.65B
| $1.81M | 2.08% | 216,600 +74,100 | +52% | +$619K |
|
|
NEXI
11
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $28K | 0.03% | 133,442 | – | – |
|
|
12
Stoke Therapeutics
STOK
$1.08B
| – | – | -346,190 | Closed | -$3.68M |
|